613 related articles for article (PubMed ID: 28122781)
1. Thyroid hormone treatment among pregnant women with subclinical hypothyroidism: US national assessment.
Maraka S; Mwangi R; McCoy RG; Yao X; Sangaralingham LR; Singh Ospina NM; O'Keeffe DT; De Ycaza AE; Rodriguez-Gutierrez R; Coddington CC; Stan MN; Brito JP; Montori VM
BMJ; 2017 Jan; 356():i6865. PubMed ID: 28122781
[TBL] [Abstract][Full Text] [Related]
2. Pregnancy outcomes in women with severe hypothyroidism.
Hirsch D; Levy S; Nadler V; Kopel V; Shainberg B; Toledano Y
Eur J Endocrinol; 2013 Sep; 169(3):313-20. PubMed ID: 23811188
[TBL] [Abstract][Full Text] [Related]
3. Effects of Levothyroxine Therapy on Pregnancy Outcomes in Women with Subclinical Hypothyroidism.
Maraka S; Singh Ospina NM; O'Keeffe DT; Rodriguez-Gutierrez R; Espinosa De Ycaza AE; Wi CI; Juhn YJ; Coddington CC; Montori VM; Stan MN
Thyroid; 2016 Jul; 26(7):980-6. PubMed ID: 27112035
[TBL] [Abstract][Full Text] [Related]
4. Associations Between Maternal Thyroid Function in Pregnancy and Obstetric and Perinatal Outcomes.
Lee SY; Cabral HJ; Aschengrau A; Pearce EN
J Clin Endocrinol Metab; 2020 May; 105(5):e2015-23. PubMed ID: 31838502
[TBL] [Abstract][Full Text] [Related]
5. Low Serum IL-17A in Pregnancy During Second Trimester Is Associated With an Increased Risk of Subclinical Hypothyroidism.
He L; Zhu X; Yang Q; Li X; Huang X; Shen C; Liu J; Zha B
Front Endocrinol (Lausanne); 2020; 11():298. PubMed ID: 32477272
[No Abstract] [Full Text] [Related]
6. Overt and subclinical hypothyroidism: who to treat and how.
Khandelwal D; Tandon N
Drugs; 2012 Jan; 72(1):17-33. PubMed ID: 22191793
[TBL] [Abstract][Full Text] [Related]
7. Thyroid-stimulating hormone, anti-thyroid antibodies, and pregnancy outcomes.
Plowden TC; Schisterman EF; Sjaarda LA; Perkins NJ; Silver R; Radin R; Kim K; Galai N; DeCherney AH; Mumford SL
Am J Obstet Gynecol; 2017 Dec; 217(6):697.e1-697.e7. PubMed ID: 28917612
[TBL] [Abstract][Full Text] [Related]
8. Five-year follow-up for women with subclinical hypothyroidism in pregnancy.
Shields BM; Knight BA; Hill AV; Hattersley AT; Vaidya B
J Clin Endocrinol Metab; 2013 Dec; 98(12):E1941-5. PubMed ID: 24217906
[TBL] [Abstract][Full Text] [Related]
9. Thyroid hormone early adjustment in pregnancy (the THERAPY) trial.
Yassa L; Marqusee E; Fawcett R; Alexander EK
J Clin Endocrinol Metab; 2010 Jul; 95(7):3234-41. PubMed ID: 20463094
[TBL] [Abstract][Full Text] [Related]
10. Thyroid Laboratory Testing and Management in Women on Thyroid Replacement Before Pregnancy and Associated Pregnancy Outcomes.
Lemieux P; Yamamoto JM; Nerenberg KA; Metcalfe A; Chin A; Khurana R; Donovan LE
Thyroid; 2021 May; 31(5):841-849. PubMed ID: 33108964
[No Abstract] [Full Text] [Related]
11. First trimester thyroid stimulating hormone as an independent risk factor for adverse pregnancy outcome.
Arbib N; Hadar E; Sneh-Arbib O; Chen R; Wiznitzer A; Gabbay-Benziv R
J Matern Fetal Neonatal Med; 2017 Sep; 30(18):2174-2178. PubMed ID: 27677438
[TBL] [Abstract][Full Text] [Related]
12. Adequate levothyroxine doses for the treatment of hypothyroidism newly discovered during pregnancy.
Abalovich M; Vázquez A; Alcaraz G; Kitaigrodsky A; Szuman G; Calabrese C; Astarita G; Frydman M; Gutiérrez S
Thyroid; 2013 Nov; 23(11):1479-83. PubMed ID: 23731335
[TBL] [Abstract][Full Text] [Related]
13. Pre-eclampsia, soluble fms-like tyrosine kinase 1, and the risk of reduced thyroid function: nested case-control and population based study.
Levine RJ; Vatten LJ; Horowitz GL; Qian C; Romundstad PR; Yu KF; Hollenberg AN; Hellevik AI; Asvold BO; Karumanchi SA
BMJ; 2009 Nov; 339():b4336. PubMed ID: 19920004
[TBL] [Abstract][Full Text] [Related]
14. Thyroid replacement therapy, thyroid stimulating hormone concentrations, and long term health outcomes in patients with hypothyroidism: longitudinal study.
Thayakaran R; Adderley NJ; Sainsbury C; Torlinska B; Boelaert K; Šumilo D; Price M; Thomas GN; Toulis KA; Nirantharakumar K
BMJ; 2019 Sep; 366():l4892. PubMed ID: 31481394
[TBL] [Abstract][Full Text] [Related]
15. A first-trimester serum TSH in the 4-10 mIU/L range is associated with obstetric complications in thyroid peroxidase antibody-negative women.
Magri F; Bellingeri C; De Maggio I; Croce L; Coperchini F; Rotondi M; Chiovato L; Spinillo A; Beneventi F
J Endocrinol Invest; 2023 Jul; 46(7):1407-1414. PubMed ID: 36562959
[TBL] [Abstract][Full Text] [Related]
16. Effects of Levothyroxine on Pregnant Women With Subclinical Hypothyroidism, Negative for Thyroid Peroxidase Antibodies.
Nazarpour S; Ramezani Tehrani F; Simbar M; Tohidi M; Minooee S; Rahmati M; Azizi F
J Clin Endocrinol Metab; 2018 Mar; 103(3):926-935. PubMed ID: 29126290
[TBL] [Abstract][Full Text] [Related]
17. Outcome of in vitro fertilization in women with subclinical hypothyroidism.
Cai Y; Zhong L; Guan J; Guo R; Niu B; Ma Y; Su H
Reprod Biol Endocrinol; 2017 May; 15(1):39. PubMed ID: 28545515
[TBL] [Abstract][Full Text] [Related]
18. Iodine supplementation during pregnancy of hypothyroid women treated with L-thyroxine neither influences neonatal TSH nor prevents decrease in maternal free thyroid hormone concentrations in second and third trimesters.
Jastrzębska H; Kochman M; Bartoszewicz Z; Ołtarzewski M; Dębski R; Zgliczyński W
Endokrynol Pol; 2016; 67(4):367-74. PubMed ID: 27387243
[TBL] [Abstract][Full Text] [Related]
19. Diagnosis and management of subclinical hypothyroidism in pregnancy.
Negro R; Stagnaro-Green A
BMJ; 2014 Oct; 349():g4929. PubMed ID: 25288580
[TBL] [Abstract][Full Text] [Related]
20. Impact of TPOAb-negative maternal subclinical hypothyroidism in early pregnancy on adverse pregnancy outcomes.
Zhu P; Chu R; Pan S; Lai X; Ran J; Li X
Ther Adv Endocrinol Metab; 2021; 12():20420188211054690. PubMed ID: 34733468
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
